Trial Profile
Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Alfuzosin; Cholestenone 5-alpha reductase inhibitors; Doxazosin; Finasteride; Tamsulosin; Terazosin
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors GSK
- 22 Sep 2011 New trial record